Results 71 to 80 of about 363,935 (339)

<em>Tada</em>, <em>kada</em>, <em>šiada</em>, <em>andai</em>, <em>idant</em>

Baltistica, 2011
LITH. TADA, KADA, ŠIADA, ANDAI, IDANTSummaryThe author discusses the origin of the Lithuanian forms tada, kada, šiada; kadai, kadaise kadan, kadangi; andai; idant etc. and concludes the following:The Lithuanian compounds of this type are related to the corresponding Slavic and Indo-Iranian compounds.
openaire   +3 more sources

Durable B‐Cell Impairment While Sparing IgA B Cells After Ocrelizumab Therapy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Ocrelizumab (OCR), a humanized anti‐CD20 monoclonal antibody, is highly efficient in relapsing–remitting multiple sclerosis (RR‐MS). We assessed early cellular B‐cell profiles in patients prior to OCR treatment, on OCR treatment, and after 15 months of therapy discontinuation.
Alexandra Garcia, Stephane Rodriguez, Emilie Dugast, Christine Lebrun‐Frenay, Eric Thouvenot, Jérôme de Sèze, Emmanuelle Le Page, Sandra Vukusic, Inès Doghri, Eric Berger, Olivier Casez, Pierre Labauge, Aurélie Ruet, Catarina Raposo, Fabienne Le Frère, Arnaud B. Nicot, Sandrine Wiertlewski, Pierre‐Antoine Gourraud, Laure Michel, Laureline Berthelot, David‐Axel Laplaud   +20 more
wiley   +1 more source

Simulation of a mechanical thrombectomy device based in the use of self-expandable stents for the blood clots extraction [PDF]

, 2011
Recently, we have presented some studies concerning the analysis, design and optimization of one experimental device developed in the UK - GPTAD - which has been designed to remove blood clots without the need to make contact with the clot itself ...
Martínez Muneta, María Luisa, Romero Rey, Gregorio   +1 more
core   +2 more sources

Long‐Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives This ongoing, open‐label extension study is evaluating the long‐term safety, tolerability, and efficacy of givinostat, a Class I and II histone deacetylase inhibitor, in patients with Duchenne muscular dystrophy (DMD). Methods The recruited patients completed one of two prior clinical studies (one Phase 2 and one Phase 3 [EPIDYS ...
Craig M. McDonald, Michela Guglieri, Dragana Vučinić, Gyula Acsadi, John F. Brandsema, Claudio Bruno, Erika L. Finanger, Amy Harper, Mercedes Lopez Lobato, Riccardo Masson, Nuria Muelas, Francina Munell, Yoram Nevo, Yann Péréon, Han Phan, Valeria A. Sansone, Mariacristina Scoto, Tracey Willis, Richard S. Finkel, Krista Vandenborne, Sara Cazzaniga, Silvia Montrasio, Federica Alessi, Paolo Bettica, Eugenio Mercuri, for the Givinostat Study 51 Investigators, the Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study (DNHS) Investigators, the ImagingDMD Investigators, Enrico Bertini, Giacomo Pietro Comi, Eugenio Maria Mercuri, Giuseppe Vita, Sonia Messina, Claudio Bruno, Riccardo Masson, Valeria Sansone, Nathalie Goemans, Liesbeth De Waele, Laurent Servais, Teresa Gidaro, Odile Boespflug‐Tanguy, Yann Péréon, Jessika Johannsen, Astrid Blaschek, Ulrike Schara‐Schmidt, Erik Niks, Imelda de Groot, Saskia Houwen‐van Opstal, Andres Nascimento, Juan Jesus Vilchez, Nuria Muelas, Francina Munell, Marcos Madruga Garrido, Mercedes Lopez Lobato, Michaela Guglieri, Tracey Willis, Stefan Spinty, Daniel Hawcutt, Mariacristina Scoto, Jean K. Mah, Laura McAdam, Kathryn Selby, Katherine Mathews, Craig McDonald, Craig Zaidman, Barry Byrne, John Brandsema, Gyula Acsadi, Chamindra Laverty, Amy Harper, Erika Finanger, Han Phan, Yoram Nevo, Vedrana Milic Rasic, Dragana Vucinic   +74 more
wiley   +1 more source

Morphological spectrum of gamma rays and ems induced viable mutants in cowpea (Vigna unguiculata (L.) Walp)

Electronic Journal of Plant Breeding, 2020
Seeds of cowpea (Vigna unguiculata (L.) Walp) variety CO 7 and Tirunelveli local were treated with gamma ray doses at 150, 200, 250, 300 and 350 Gy and EMS (Ethyl Methane Sulphonate) doses at 5, 10, 15, 20 and 25 mM.
M. Preethi and A. Muthuswamy
doaj   +1 more source

Who needs engine monitoring? [PDF]

Operational evaluations of engine monitoring systems (EMS) are discussed.
Pettigrew, J. L.
core   +1 more source

Exosome Proteomics of SOD1D90A Mutation Suggest Early Disease Mechanisms, and FN1 as a Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease. Super oxide dismutase 1 (SOD1) gene mutations cause ALS, and the D90A mutation is associated with primarily upper motor neuron (UMN) loss. Objective Our goal is to reveal the early cellular events in ALS pathology and identify potential pharmacokinetic biomarkers, using well ...
Mukesh Gautam, Ali Laith, Aslihan Gunel, Melda Yilmaz, Nazli Basak, Halil Idrisoglu, P. Hande Ozdinler   +6 more
wiley   +1 more source

Integrating emergency medical services and palliative care: A nominal group technique

African Journal of Primary Health Care & Family Medicine
Background: The need for integrated healthcare has been increasingly recognised because of mounting challenges associated with the proliferation of injuries and noncommunicable diseases.
Caleb H. Gage, Liz Gwyther, Julia Ambler, Jan Burke, Katya Evans, Linley Holmes, René Krause, Kaleb Lachenicht, Danielle Lincoln, Kerene Payne, Mpho Ratshikana-Moloko, Charnelle Stander, Willem Stassen   +12 more
doaj   +1 more source

Socioeconomic Disparities in Prehospital Emergency Care in a Danish Tax-Financed Healthcare System: Nationwide Cohort Study

Clinical Epidemiology, 2022
Juliane Frydenlund,1 Julie Mackenhauer,1 Erika F Christensen,2– 4 Helle Collatz Christensen,5 Ulla Væggemose,6,7 Jacob Steinmetz,8,9 Søren Paaske Johnsen1 1Department of Clinical Medicine, Aalborg University, Aalborg East, 9220, Denmark; 2Department of ...
Frydenlund J, Mackenhauer J, Christensen EF, Christensen HC, Væggemose U, Steinmetz J, Johnsen SP   +6 more
doaj  

Growth Differentiation Factor 15 Elevation in the Central Nervous System Is Associated With Failure to Thrive in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Alexander disease (AxD) is a severe neurodegenerative disorder caused by gain‐of‐function mutations in the gene for GFAP, which lead to protein aggregation and a primary astrocytopathy. Symptoms vary, but failure to thrive (FTT) and frequent emesis are common and cause significant morbidity. Here we investigate GDF15, a member of the
Tracy L. Hagemann, Michelle M. Sonsalla, Cora Luzinski, Fernando Zacahua, David A. Harris, Dudley W. Lamming, Albee Messing   +6 more
wiley   +1 more source